cAMP-dependent protein kinase activity in major depression

American Journal of Psychiatry

Volumn 153, Issue 8, 1996, Pages 1037-1042

  Shelton, Richard C ^a   Manier, D Hal ^a   Sulser, Fridolin ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ISOPRENALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; PHOSPHORYLATION; PRIORITY JOURNAL; SKIN FIBROBLAST;

EID: 0029810672     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.8.1037     Document Type: Article

References (47)

1. Pryor JC, Sulser F: Evolution of the monoamine hypotheses of depression, in Biological Aspects of Affective Disorders. Edited by Horton RW, Katona C. London, Academic Press, 1991, pp 77-94
2. Vetulani J, Sulser F: Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP generating system in limbic forebrain. Nature 1975; 257:495-496
3. Vetulani J, Stawarz RJ, Dingell JV, Sulser F: A possible common mechanism of action of antidepressant treatments: reduction in the sensitivity of the noradrenergic cyclic AMP generating system in the rat limbic forebrain. Naunyn Schmiedebergs Arch Pharmacol 1976; 293:109-114
4. Banerjee SP, Kung LS, Riggi SJ, Chanda SK: Development of beta adrenergic receptor subsensitivity by antidepressants. Nature 1976; 268:455-456
5. Extein I, Tallman J, Smith CC, Goodwin FK: Changes in lymphocyte beta-adrenergic receptors in depression and mania. Psychiatry Res 1979; 1:191-197
6. Pandey GN, Janicak P, Davis JM: Studies of beta-adrenergic receptors in leukocytes of patients with affective illness and effects of antidepressant drugs. Psychopharmacol Bull 1985; 21:603-609
7. Pandey GN, Janicak PG, Davis JM: Decreased beta-adrenergic receptors in the leukocytes of depressed patients. Psychiatry Res 1987; 22:265-273
8. Wood K, Whiting K, Coppen A: Lymphocyte beta-adrenergic receptor density of patients with recurrent affective illness. J Affect Disord 1986; 10:3-8
9. Magliozzi JR, Gietzen D, Maddock RJ, Haack D, Doran AR, Goodman T, Weiler PG: Lymphocyte beta-adrenoceptor density in patients with unipolar depression and normal controls. Biol Psychiatry 1989; 26:15-21
10. Jeanningros R, Mazzola P, Azorin JM, Samuelian Massat C, Tissot R: β-Adrenoceptor density of intact mononuclear leukocytes in subgroups of depressive disorders. Biol Psychiatry 1991; 29: 789-798
11. Pandey GN, Dysken MW, Garver DL, Davis JM: Beta-adrenergic receptor function in affective illness. Am J Psychiatry 1979; 136:675-678
12. Mann JJ, Brown RP, Halper JP, Sweeney JA, Kocsis JH, Stokes PE, Bilezikian JP: Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation. N Engl J Med 1985; 313:715-720
13. Ebstein RP, Lerer B, Shapira B, Shemesh Z, Moscivich DG, Kindler S: Cyclic AMP second-messenger signal amplification in depression. Br J Psychiatry 1988; 152:665-669
14. Halper JP, Brown RP, Sweeney JA, Kocsis JH, Peters A, Mann JJ: Blunted β-adrenergic responsivity of peripheral blood mononuclear cells in endogenous depression: isoproterenol dose-response studies. Arch Gen Psychiatry 1988; 45:241-244
15. Mazzola-Pomietto P, Azorin J-M, Tramoni V, Jeanningros R: Relation between lymphocyte β-adrenergic responsivity and the severity of depressive disorders. Biol Psychiatry 1994; 35:920-925
16. Tohmeh JF, Cryer PE: Biphasic adrenergic modulation of β-adrenergic receptors in man: agonist-induced early increment and late decrement in β-adrenergic receptor number. J Clin Invest 1980; 65:836-840
17. Fraser J, Nadeau J, Robertson D, Wood AJ: Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol. J Clin Invest 1981; 67:1777-1784
18. Feldman RD, Limbird LE, Nadeau J, Robertson D, Wood AJ: Leukocyte beta-receptor alterations in hypertensive subjects. J Clin Invest 1984; 73:648-653
19. Lima DR, Turner P: Propranolol increases reduced beta-receptor function in severely anxious patients (letter). Lancet 1983; 2: 1505
20. Brown SL, Charney DS, Woods SW, Heninger GR, Tallman J: Lymphocyte β-adrenergic binding in panic disorder. Psychopharmacology (Berl) 1988; 94:24-28
21. Maddock RJ, Carter CS, Magliozzi JR, Gietzen DW: Evidence that decreased function of lymphocyte β adrenoceptors reflects regulatory and adaptive processes in panic disorder with agoraphobia. Am J Psychiatry 1993; 150:1219-1225
22. Lake CR, Pickar D, Ziegler M, Lipper S, Slater S, Murphy DL: High plasma norepinephrine levels in patients with major affective disorder. Am J Psychiatry 1982; 139:1315-1318
23. Esler M, Turbott J, Schwarz R, Leonard P, Bobik A, Skews H, Jackman G: The peripheral kinetics of norepinephrine in depressive illness. Arch Gen Psychiatry 1982; 39:295-300
24. Barnes RF, Veith RC, Borson S, Verhey J, Raskind MA, Halter JB: High levels of plasma catecholamines in dexamethasone-resistant depressed patients. Am J Psychiatry 1983; 140:1623-1625
25. Rudorfer MV, Ross RJ, Linnoila M, Sherer MA, Potter WZ: Exaggerated orthostatic responsivity of plasma norepinephrine in depression. Arch Gen Psychiatry 1985; 42:1186-1192
26. Maas JW, Koslow SH, Davis J, Katz M, Frazer A, Bowden CL, Berman N, Gibbons R, Stokes P, Landis DH: Catecholamine metabolism and disposition in healthy and depressed subjects. Arch Gen Psychiatry 1987; 44:337-344
27. Buckholtz NS, Davies AO, Rudorfer MV, Golden RN, Potter WZ: Lymphocyte beta adrenergic receptor function versus catecholamines in depression. Biol Psychiatry 1988; 24:451-457
28. Wyatt RJ, Portnoy B, Kupfer KJ, Snyder F, Engelman K: Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry 1971; 24:65-70
29. Berettini WH, Bardakjian J, Barnett AL Jr, Nurnberger JI Jr, Gershon ES: Beta-adrenoceptor function in human adult skin fibroblasts: a study of manic-depressive illness, in Ciba Foundation Symposium 129: Antidepressants and Receptor Function. Edited by Clark S. Chichester, England, John Wiley & Sons, 1986, pp 30-41
30. Berettini WH, Bardakjian J, Cappellari CB, Barnett AL, Albright A, Nurnberger JI Jr, Gershon ES: Skin fibroblast beta-adrenergic receptor function in manic-depressive illness. Biol Psychiatry 1987; 22:1439-1443
31. Kay G, Sargeant M, McGuffin P, Whatley S, Marchbanks R, Baldwin D, Montgomery S, Elliott JM: The lymphoblast beta-adrenergic receptor in bipolar depressed patients: characterization and down-regulation. J Affect Disord 1993; 27:163-172
32. Kay G, Sargeant W, McGuffin P, Whatley S, Marchbanks R, Bullock T, Montgomery S, Elliott JM: The lymphoblast beta-adrenergic receptor in bipolar depressed patients: effect of chronic incubation with lithium chloride. J Affect Disord 1994; 30: 185-192
33. Benovic JL, Bouvier M, Caron MG, Lefkowitz RJ: Regulation of adenylyl cyclase-coupled beta-adrenergic receptors. Annu Rev Cell Biol 1988; 44:405-428
34. Cheung AH, Dixon RAF, Hill WS, Sigal IT, Shrader CJ: Separation of the structural requirements for agonist-promoted activation and sequestration of the β-adrenergic receptor. Mol Pharmacol 1990; 37:775-779
35. Taylor SS, Buechler JA, Yonemoto Y: cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu Rev Biochem 1990; 59:971-1005
36. Walsh DA, Ashby CD: Protein kinases: aspects of their regulation and diversity. Recent Prog Horm Res 1973; 29:329-359
37. Nestler EJ, Greengard P: Protein Phosphorylation in the Nervous System. New York, John Wiley & Sons, 1984
38. Nestler EJ, Terwilliger RZ, Duman RS: Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J Neurochem 1989; 53:1644-1647
39. Winston SM, Hayward MD, Nestler EJ, Duman RS: Chronic electroconvulsive seizures down-regulate expression of the immediate-early genes c-fos and c-jun in rat cerebral cortex. J Neurochem 1990; 54:1920-1925
40. Leviel V, Fayada C, Guibert B, Chaminade M, Machek G, Mallet J, Biguet NC: Short and long-term alterations of gene expression in limbic structures by repeated electroconvulsive-induced seizures. J Neurochem 1990; 54:899-904
41. Rossby SP, Huang M, Burt A, Gillespie DD, Sulser F: The "serotonin/norepinephrine/glucocorticoid link" as a target for antidepressant drug action (abstract). Neuropsychopharmacology 1994; 10:1735
42. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R - Patient Version 1.0 (SCID-P). Washington, DC, American Psychiatric Press, 1990
43. Edelstein SB, Breakefield XO: Physico-chemical methodologies, in Psychiatry Research. Edited by Hanin I, Koslow SH. New York, Raven Press, 1980, pp 199-243
44. Lowry DH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
45. Perez J, Tinell D, Brunello N, Racagni G: cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment. Eur J Pharmacol 1989; 172:305-316
46. Perez J, Mori S, Caivano M, Fumagalli F, Pezzetta B, Tascedda F, Brunello N, Racagni G: cAMP protein kinase as an intracellular target for the action of antidepressant drugs (abstract). Neuropsychopharmacology 1994; 10:1715
47. Taylor SS: cAMP dependent protein kinase. J Biol Chem 1989; 264:8443-8446